(Total Views: 200)
Posted On: 06/15/2023 10:05:46 AM
Post# of 46

$ALDX News Article - Aldeyra Therapeutics Announces Achievement of Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE?2 Trial of Reproxalap in Allergic Conjunctivitis https://marketwirenews.com/news-releases/alde...79553.html


My Twitter: WhyteStocks